Technical / White Paper

Fill-Finish Biologics

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Curia , and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Fill-Finish Biologics

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion, while the blockbuster Keytruda could be the top-selling drug with almost $25 billion in sales.

Related resources from Curia

Supplier info centre